4-3074876-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP3BP6_ModerateBS1BS2
The NM_001388492.1(HTT):c.105_110dupGCAGCA(p.Gln36_Gln37dup) variant causes a disruptive inframe insertion change. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.039 ( 121 hom., cov: 0)
Exomes 𝑓: 0.032 ( 2534 hom. )
Consequence
HTT
NM_001388492.1 disruptive_inframe_insertion
NM_001388492.1 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.84
Publications
6 publications found
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
- Huntington diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- Lopes-Maciel-Rodan syndromeInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- juvenile Huntington diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001388492.1
BP6
Variant 4-3074876-C-CCAGCAG is Benign according to our data. Variant chr4-3074876-C-CCAGCAG is described in ClinVar as [Likely_benign]. Clinvar id is 3910356.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0388 (5117/131854) while in subpopulation AFR AF = 0.0451 (1603/35518). AF 95% confidence interval is 0.0433. There are 121 homozygotes in GnomAd4. There are 2422 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 121 AR,AD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTT | NM_001388492.1 | c.105_110dupGCAGCA | p.Gln36_Gln37dup | disruptive_inframe_insertion | Exon 1 of 67 | ENST00000355072.11 | NP_001375421.1 | |
HTT | NM_002111.8 | c.105_110dupGCAGCA | p.Gln36_Gln37dup | disruptive_inframe_insertion | Exon 1 of 67 | NP_002102.4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0389 AC: 5122AN: 131756Hom.: 121 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
5122
AN:
131756
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0318 AC: 38958AN: 1223798Hom.: 2534 Cov.: 0 AF XY: 0.0322 AC XY: 19551AN XY: 607118 show subpopulations
GnomAD4 exome
AF:
AC:
38958
AN:
1223798
Hom.:
Cov.:
0
AF XY:
AC XY:
19551
AN XY:
607118
show subpopulations
African (AFR)
AF:
AC:
776
AN:
25786
American (AMR)
AF:
AC:
926
AN:
30256
Ashkenazi Jewish (ASJ)
AF:
AC:
509
AN:
22716
East Asian (EAS)
AF:
AC:
270
AN:
29088
South Asian (SAS)
AF:
AC:
2001
AN:
72150
European-Finnish (FIN)
AF:
AC:
987
AN:
32484
Middle Eastern (MID)
AF:
AC:
158
AN:
3774
European-Non Finnish (NFE)
AF:
AC:
31724
AN:
955770
Other (OTH)
AF:
AC:
1607
AN:
51774
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
1211
2421
3632
4842
6053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0388 AC: 5117AN: 131854Hom.: 121 Cov.: 0 AF XY: 0.0382 AC XY: 2422AN XY: 63406 show subpopulations
GnomAD4 genome
AF:
AC:
5117
AN:
131854
Hom.:
Cov.:
0
AF XY:
AC XY:
2422
AN XY:
63406
show subpopulations
African (AFR)
AF:
AC:
1603
AN:
35518
American (AMR)
AF:
AC:
525
AN:
13406
Ashkenazi Jewish (ASJ)
AF:
AC:
81
AN:
3190
East Asian (EAS)
AF:
AC:
53
AN:
4120
South Asian (SAS)
AF:
AC:
86
AN:
3908
European-Finnish (FIN)
AF:
AC:
184
AN:
7368
Middle Eastern (MID)
AF:
AC:
5
AN:
252
European-Non Finnish (NFE)
AF:
AC:
2499
AN:
61476
Other (OTH)
AF:
AC:
70
AN:
1816
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.532
Heterozygous variant carriers
0
216
432
648
864
1080
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.